Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 41 to 50 of 511

TitleReference numberPublishedLast updated
Marstacimab for treating severe haemophilia A or B in people 12 years and over without anti-factor antibodiesTA1073
Headaches in over 12s: diagnosis and managementCG150
Somapacitan for treating growth hormone deficiency in people 3 to 17 yearsTA1066
Brentuximab vedotin in combination for untreated stage 3 or 4 CD30-positive Hodgkin lymphomaTA1059
Omaveloxolone for treating Friedreich's ataxia in people 16 years and over (terminated appraisal)TA1061
Falls: assessment and prevention in older people and in people 50 and over at higher riskNG249
Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and overHST33
Tislelizumab in combination for untreated advanced non-small-cell lung cancer (terminated appraisal)TA1058
Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and overTA1054
Burosumab for treating X-linked hypophosphataemia in children and young peopleHST8

Results per page

  1. 10
  2. 25
  3. 50
  4. All